Premium
Thromboprophylaxis with low molecular weight heparin in thrombophilia‐complicated pregnancy
Author(s) -
Ebina Yasuhiko,
Yamada Hideto,
Kato Emi H.,
Yamamoto Ritsu,
Sakuragi Noriaki,
Fujimoto Seiichiro
Publication year - 2002
Publication title -
journal of obstetrics and gynaecology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.597
H-Index - 50
eISSN - 1447-0756
pISSN - 1341-8076
DOI - 10.1046/j.1341-8076.2002.00050.x
Subject(s) - medicine , thrombophilia , low molecular weight heparin , antiphospholipid syndrome , pregnancy , heparin , obstetrics , thrombosis , surgery , genetics , biology
We treated three thrombophilia‐complicated pregnant women (two antiphospholipid antibody syndrome, one protein C deficiency) with low molecular weight heparin (dalteparin). All three pregnancies including one twin pregnancy ended in live births without a decrease in bone mineral density. This treatment modality was effective and safe preventing thrombosis during their pregnancies.